Anti-Trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologies.

Cross-reactive antibodies are characterized by their recognition of antigens that are different from the trigger immunogen. This happens when the similarity between two different antigenic determinants becomes adequate enough to enable a specific binding with such cross-reactive antibodies. In the p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Esber S Saba, Lucie Gueyffier, Marie-Laure Dichtel-Danjoy, Bruno Pozzetto, Thomas Bourlet, François Gueyffier, Yahia Mekki, Hans Pottel, Ester C Sabino, Philippe Vanhems, Maan A Zrein
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9aa4f913716b413aba473498a8b8732a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9aa4f913716b413aba473498a8b8732a
record_format dspace
spelling oai:doaj.org-article:9aa4f913716b413aba473498a8b8732a2021-11-18T08:54:55ZAnti-Trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologies.1932-620310.1371/journal.pone.0074493https://doaj.org/article/9aa4f913716b413aba473498a8b8732a2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24069315/?tool=EBIhttps://doaj.org/toc/1932-6203Cross-reactive antibodies are characterized by their recognition of antigens that are different from the trigger immunogen. This happens when the similarity between two different antigenic determinants becomes adequate enough to enable a specific binding with such cross-reactive antibodies. In the present manuscript, we report the presence, at an "abnormal" high frequency, of antibodies in blood samples from French human subjects cross-reacting with a synthetic-peptide antigen derived from a Trypanosoma cruzi (T. cruzi) protein sequence. As the vector of T. cruzi is virtually confined to South America, the parasite is unlikely to be the trigger immunogen of the cross-reactive antibodies detected in France. At present, the cross-reactive antibodies are measured by using an in-house ELISA method that employs the T. cruzi -peptide antigen. However, to underline their cross-reactive characteristics, we called these antibodies "Trypanosoma cruzi Cross Reactive Antibodies" or TcCRA. To validate their cross-reactive nature, these antibodies were affinity-purified from plasma of healthy blood donor and were then shown to specifically react with the T. cruzi parasite by immunofluorescence. Seroprevalence of TcCRA was estimated at 45% in serum samples of French blood donors while the same peptide-antigen reacts with about 96% of T. cruzi -infected Brazilian individuals. In addition, we compared the serology of TcCRA to other serologies such as HSV 1/2, EBV, HHV-6, CMV, VZV, adenovirus, parvovirus B19, mumps virus, rubella virus, respiratory syncytial virus, measles and enterovirus. No association was identified to any of the tested viruses. Furthermore, we tested sera from different age groups for TcCRA and found a progressive acquisition starting from early childhood. Our findings show a large seroprevalence of cross-reactive antibodies to a well-defined T. cruzi antigen and suggest they are induced by a widely spread immunogen, acquired from childhood. The etiology of TcCRA and their clinical relevance still need to be investigated.Esber S SabaLucie GueyffierMarie-Laure Dichtel-DanjoyBruno PozzettoThomas BourletFrançois GueyffierYahia MekkiHans PottelEster C SabinoPhilippe VanhemsMaan A ZreinPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 9, p e74493 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Esber S Saba
Lucie Gueyffier
Marie-Laure Dichtel-Danjoy
Bruno Pozzetto
Thomas Bourlet
François Gueyffier
Yahia Mekki
Hans Pottel
Ester C Sabino
Philippe Vanhems
Maan A Zrein
Anti-Trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologies.
description Cross-reactive antibodies are characterized by their recognition of antigens that are different from the trigger immunogen. This happens when the similarity between two different antigenic determinants becomes adequate enough to enable a specific binding with such cross-reactive antibodies. In the present manuscript, we report the presence, at an "abnormal" high frequency, of antibodies in blood samples from French human subjects cross-reacting with a synthetic-peptide antigen derived from a Trypanosoma cruzi (T. cruzi) protein sequence. As the vector of T. cruzi is virtually confined to South America, the parasite is unlikely to be the trigger immunogen of the cross-reactive antibodies detected in France. At present, the cross-reactive antibodies are measured by using an in-house ELISA method that employs the T. cruzi -peptide antigen. However, to underline their cross-reactive characteristics, we called these antibodies "Trypanosoma cruzi Cross Reactive Antibodies" or TcCRA. To validate their cross-reactive nature, these antibodies were affinity-purified from plasma of healthy blood donor and were then shown to specifically react with the T. cruzi parasite by immunofluorescence. Seroprevalence of TcCRA was estimated at 45% in serum samples of French blood donors while the same peptide-antigen reacts with about 96% of T. cruzi -infected Brazilian individuals. In addition, we compared the serology of TcCRA to other serologies such as HSV 1/2, EBV, HHV-6, CMV, VZV, adenovirus, parvovirus B19, mumps virus, rubella virus, respiratory syncytial virus, measles and enterovirus. No association was identified to any of the tested viruses. Furthermore, we tested sera from different age groups for TcCRA and found a progressive acquisition starting from early childhood. Our findings show a large seroprevalence of cross-reactive antibodies to a well-defined T. cruzi antigen and suggest they are induced by a widely spread immunogen, acquired from childhood. The etiology of TcCRA and their clinical relevance still need to be investigated.
format article
author Esber S Saba
Lucie Gueyffier
Marie-Laure Dichtel-Danjoy
Bruno Pozzetto
Thomas Bourlet
François Gueyffier
Yahia Mekki
Hans Pottel
Ester C Sabino
Philippe Vanhems
Maan A Zrein
author_facet Esber S Saba
Lucie Gueyffier
Marie-Laure Dichtel-Danjoy
Bruno Pozzetto
Thomas Bourlet
François Gueyffier
Yahia Mekki
Hans Pottel
Ester C Sabino
Philippe Vanhems
Maan A Zrein
author_sort Esber S Saba
title Anti-Trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologies.
title_short Anti-Trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologies.
title_full Anti-Trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologies.
title_fullStr Anti-Trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologies.
title_full_unstemmed Anti-Trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologies.
title_sort anti-trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologies.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/9aa4f913716b413aba473498a8b8732a
work_keys_str_mv AT esberssaba antitrypanosomacruzicrossreactiveantibodiesdetectedathighrateinnonexposedindividualslivinginnonendemicregionsseroprevalenceandassociationtootherviralserologies
AT luciegueyffier antitrypanosomacruzicrossreactiveantibodiesdetectedathighrateinnonexposedindividualslivinginnonendemicregionsseroprevalenceandassociationtootherviralserologies
AT marielauredichteldanjoy antitrypanosomacruzicrossreactiveantibodiesdetectedathighrateinnonexposedindividualslivinginnonendemicregionsseroprevalenceandassociationtootherviralserologies
AT brunopozzetto antitrypanosomacruzicrossreactiveantibodiesdetectedathighrateinnonexposedindividualslivinginnonendemicregionsseroprevalenceandassociationtootherviralserologies
AT thomasbourlet antitrypanosomacruzicrossreactiveantibodiesdetectedathighrateinnonexposedindividualslivinginnonendemicregionsseroprevalenceandassociationtootherviralserologies
AT francoisgueyffier antitrypanosomacruzicrossreactiveantibodiesdetectedathighrateinnonexposedindividualslivinginnonendemicregionsseroprevalenceandassociationtootherviralserologies
AT yahiamekki antitrypanosomacruzicrossreactiveantibodiesdetectedathighrateinnonexposedindividualslivinginnonendemicregionsseroprevalenceandassociationtootherviralserologies
AT hanspottel antitrypanosomacruzicrossreactiveantibodiesdetectedathighrateinnonexposedindividualslivinginnonendemicregionsseroprevalenceandassociationtootherviralserologies
AT estercsabino antitrypanosomacruzicrossreactiveantibodiesdetectedathighrateinnonexposedindividualslivinginnonendemicregionsseroprevalenceandassociationtootherviralserologies
AT philippevanhems antitrypanosomacruzicrossreactiveantibodiesdetectedathighrateinnonexposedindividualslivinginnonendemicregionsseroprevalenceandassociationtootherviralserologies
AT maanazrein antitrypanosomacruzicrossreactiveantibodiesdetectedathighrateinnonexposedindividualslivinginnonendemicregionsseroprevalenceandassociationtootherviralserologies
_version_ 1718421156575313920